News

AZoLifeSciences on MSN2d
What’s Next for Enzyme Engineering in Synthetic Biology?
CRISPR-associated transposases (CAST) revolutionize enzyme engineering, enabling precise modifications for improved ...
One billion-year-old rules of protein stability revealed; could lead to faster drug and enzyme design
Proteins are life's molecular workhorses, doing everything from turning sunlight into food to fighting viruses. They are ...
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.